SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-073897
Filing Date
2024-03-21
Accepted
2024-03-21 16:32:01
Documents
13
Period of Report
2024-03-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d801406d8k.htm   iXBRL 8-K 23975
  Complete submission text file 0001193125-24-073897.txt   145934

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20240318.xsd EX-101.SCH 2851
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20240318_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20240318_pre.xml EX-101.PRE 11262
17 EXTRACTED XBRL INSTANCE DOCUMENT d801406d8k_htm.xml XML 3720
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 24771861
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)